Serum Institute seeks Covishield's booster dose approval from DCGI

Serum Institute of India (SII) has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.

from IndiaTV: Google News Feed https://ift.tt/2ZMiUn4